-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Reiterates Speculative Buy on ImmunoPrecise Antibodies, Maintains $3 Price Target

Benzinga·04/01/2025 14:44:49
Listen to the news
Benchmark analyst Robert Wasserman reiterates ImmunoPrecise Antibodies (NASDAQ:IPA) with a Speculative Buy and maintains $3 price target.